Kindly MD (KDLYW) Competitors $0.30 +0.01 (+3.51%) (As of 09/18/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends KDLYW vs. AONCW, AONC, PIIIW, TOIIW, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, and ALVOWShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include American Oncology Network (AONCW), American Oncology Network (AONC), P3 Health Partners (PIIIW), Oncology Institute (TOIIW), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), and Alvotech (ALVOW). These companies are all part of the "medical" sector. Kindly MD vs. American Oncology Network American Oncology Network P3 Health Partners Oncology Institute 180 Life Sciences 60 Degrees Pharmaceuticals Aclarion Ainos Alpha Tau Medical Alvotech Kindly MD (NASDAQ:KDLYW) and American Oncology Network (NASDAQ:AONCW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends, earnings and community ranking. Is KDLYW or AONCW more profitable? Company Net Margins Return on Equity Return on Assets Kindly MDN/A N/A N/A American Oncology Network N/A N/A N/A Does the media refer more to KDLYW or AONCW? In the previous week, Kindly MD's average media sentiment score of 1.91 beat American Oncology Network's score of 0.00 indicating that Kindly MD is being referred to more favorably in the media. Company Overall Sentiment Kindly MD Very Positive American Oncology Network Neutral Which has better valuation and earnings, KDLYW or AONCW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindly MD$3.10MN/AN/AN/AN/AAmerican Oncology Network$1.34BN/AN/AN/AN/A Does the MarketBeat Community prefer KDLYW or AONCW? Kindly MD and American Oncology Network both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformKindly MDN/AN/AAmerican Oncology NetworkN/AN/A Do analysts rate KDLYW or AONCW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kindly MD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAmerican Oncology Network 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryKindly MD and American Oncology Network tied by winning 1 of the 2 factors compared between the two stocks. Ad Porter & CompanyWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLYW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLYW vs. The Competition Export to ExcelMetricKindly MDMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.24B$5.70B$8.27BDividend YieldN/A3.79%5.00%4.07%P/E RatioN/A238.84139.5418.76Price / SalesN/A41,363.141,622.8070.71Price / CashN/A12.9437.6531.82Price / BookN/A2.224.834.53Net IncomeN/A$51.59M$116.15M$225.19M7 Day Performance2.43%0.18%3.75%4.98%1 Month PerformanceN/A-0.57%8.97%8.40%1 Year PerformanceN/A0.68%28.94%11.88% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AONCWAmerican Oncology Network0 of 5 stars0.00 / 5 stars$0.10flatN/AN/A$0.00$1.34B0.001,525Gap UpHigh Trading VolumeAONCAmerican Oncology Network0 of 5 stars0.00 / 5 stars$3.55-2.7%N/AN/A$0.00$1.34B0.001,520News CoverageGap UpPIIIWP3 Health Partners0 of 5 stars0.00 / 5 stars$0.04+10.5%N/AN/A$0.00$1.40B0.00500Positive NewsTOIIWOncology Institute0 of 5 stars0.00 / 5 stars$0.01-43.9%N/A-90.8%$0.00$361.07M0.00660ATNFW180 Life Sciences0 of 5 stars0.00 / 5 stars$0.01-19.2%N/A-45.1%$0.00N/A0.007Positive NewsGap UpSXTPW60 Degrees Pharmaceuticals0 of 5 stars0.00 / 5 stars$0.04-37.5%N/AN/A$0.00$418,304.000.002Positive NewsACONWAclarion0 of 5 stars0.00 / 5 stars$0.04+21.7%N/A-59.4%$0.00$53,947.000.007Gap DownAIMDWAinos0 of 5 stars0.00 / 5 stars$0.04-15.9%N/A-66.9%$0.00$65,122.000.0040Positive NewsDRTSWAlpha Tau Medical0 of 5 stars0.00 / 5 stars$0.20+11.2%N/A-35.6%$0.00N/A0.0080News CoveragePositive NewsGap UpALVOWAlvotech0 of 5 stars0.00 / 5 stars$2.55flatN/AN/A$0.00$306.77M0.004Positive News Related Companies and Tools Related Companies: American Oncology Network Alternatives American Oncology Network Alternatives P3 Health Partners Alternatives Oncology Institute Alternatives 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Aclarion Alternatives Ainos Alternatives Alpha Tau Medical Alternatives Alvotech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KDLYW) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.